PAA 2.38% 20.5¢ pharmaust limited

Ann: Extension Study Begins, Analysis Suggests Survival Benefit, page-44

  1. 318 Posts.
    lightbulb Created with Sketch. 40
    Agree. That is why I mentioned that, at least in part, the note in the slide addresses your point. I asked MT about the shortest and longest survival periods earlier this year and MT mentioned it is data to be released to the market. Certainly not saying it is because of my enquiry but great to see it in this presentation. Also, I think that in the Nov 23 presentation, MT took an approach similar to how you have put it. So I think he knows it is a point worth making, but having said that, it is definitely a point worth re-iterating - just like how MT mentions at least 3 or 4 times that PH1 results will be out in 2 to 3 weeks (which is also excellent news).
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.